Hypertension Research
Online ISSN : 1348-4214
Print ISSN : 0916-9636
ISSN-L : 0916-9636
The Effects of Different Doses of Dopamine and Domperidone on Increases of Plasma Norepinephrine Induced by Cold Pressor Test in Normal Man
Aloysius G. LieverseJoop D. LefrandtArmand R.J. GirbesAndries J. SmitWepco D. Reitsma
著者情報
ジャーナル フリー

1995 年 18 巻 SupplementI 号 p. S221-S224

詳細
抄録

The effect of dopamine 1 and 3μg/kg/min i.v., of dopamine 1 and 3μg/kg/min i.v. combined with domperidone 30mg per os and of placebo infusion on plasma norepinephrine concentration before and during sympathetic stimulation by a cold pressor test was investigated in 10 healthy volunteers (1 female, 9 males, mean age 28, range 19-41). Dopamine 1μg/kg/min resulted in a blunting of the rise in plasma norepinephrine concentration during the cold pressor test, compared with placebo infusion. The addition of domperidone to dopamine 1μg/kg/min abolished this effect. Plasma norepinephrine levels during dopamine 3μg/kg/min infusion, both with and without domperidone, were not different from placebo, but significantly higher compared to dopamine 1μg/kg/min infusion. Dopamine 1 and 3μg/kg/min infusion, both with and without domperidone resulted in a blunted increase in blood pressure compared to placebo infusion. Dopamine 1μg/kg/min infusion resulted in a lower systolic blood pressure during the cold pressor test compared to dopamine 3μg/kg/min infusion. No significant changes in heart rate occurred during the cold pressor test comparing the different circumstances. We conclude that in healthy volunteers only dopamine 1μg/kg/min, but not dopamine 3μg/kglmin, blunts the increase in plasma norepinephrine concentration during a cold pressor test; this effect is abolished by pretreatment with domperidone. We presume that for dopamine 1μg/kg/min the inhibitory effects of presynaptic DA-2 receptor or α-2 adrenoceptor stimulation on plasma norepinephrine concentration predominate. When dopamine 3μg/kg/min is infused, the inhibitory effects might be counteracted by uptake-1 inhibition or enhanced synthesis and release of norepinephrine, either directly or indirectly. (Hypertens Res 1995; 18 Suppl. I: S221-S224)

著者関連情報
© The Japanese Society of Hypertension
前の記事
feedback
Top